Table 1.
Characteristics of Enrolled Patients
| Characteristic | <100-Mile Group, No. (%) | 100+-Mile Group, No. (%) | Total, No. (%) | P Value | ||||
|---|---|---|---|---|---|---|---|---|
| Overall | 630 | (55) | 506 | (45) | 1136 | (100) | ||
| Pre-HCT diagnosis | .21 | |||||||
| Leukemia or MDS | 231 | (37) | 190 | (38) | 421 | (37) | ||
| Lymphoma | 252 | (40) | 217 | (43) | 469 | (41) | ||
| Myeloma | 144 | (23) | 99 | (20) | 243 | (21) | ||
| Other | 3 | (0) | 0 | (0) | 3 | (0) | ||
| HCT type | .92 | |||||||
| Autologous | 350 | (56) | 278 | (55) | 628 | (55) | ||
| RIC allogeneic | 70 | (11) | 54 | (11) | 124 | (11) | ||
| MAC allogeneic | 210 | (33) | 174 | (34) | 384 | (34) | ||
| Years after HCT | (Missing: n = 1) | .06 | ||||||
| ≤ 4.9 years | 243 | (39) | 223 | (44) | 466 | (41) | ||
| 5+ years | 386 | (61) | 283 | (56) | 669 | (59) | ||
| Assessment method | .23 | |||||||
| Online | 560 | (89) | 438 | (87) | 998 | (88) | ||
| 70 | (11) | 68 | (13) | 138 | (12) | |||
| Current age | (Missing: n = 1) | .99 | ||||||
| ≤ 40 years | 62 | (10) | 51 | (10) | 113 | (10) | ||
| 41-64 years | 352 | (56) | 283 | (56) | 635 | (56) | ||
| ≥ 65 years | 215 | (34) | 172 | (34) | 387 | (34) | ||
| Gender | .97 | |||||||
| Male | 333 | (53) | 268 | (53) | 601 | (53) | ||
| Female | 297 | (47) | 238 | (47) | 535 | (47) | ||
| Race | (Missing: n = 24) | .18 | ||||||
| White | 580 | (94) | 471 | (96) | 1051 | (95) | ||
| Non-white | 39 | (6) | 22 | (4) | 61 | (5) | ||
| Partner status | *(Missing: n = 43) | .23 | ||||||
| Long-term partner | 463 | (77) | 388 | (80) | 851 | (78) | ||
| No long-term partner | 142 | (23) | 100 | (20) | 242 | (22) | ||
| Annual income | (Missing: n = 98) | .95 | ||||||
| ≥ $100K | 167 | (29) | 143 | (31) | 310 | (30) | ||
| $60-99.9K | 172 | (30) | 139 | (30) | 311 | (30) | ||
| $20K-$50.9K | 176 | (31) | 142 | (31) | 318 | (31) | ||
| ≤ $19.9K | 52 | (9) | 39 | (8) | 91 | (9) | ||
| Highest education | (Missing: n = 44) | .40 | ||||||
| Graduate degree | 133 | (22) | 116 | (24) | 249 | (23) | ||
| Some/all college | 395 | (65) | 321 | (66) | 716 | (65) | ||
| High school or less | 77 | (13) | 50 | (10) | 127 | (12) | ||
| Current cGVHD | (Missing: n = 708)† | .44 | ||||||
| None | 87 | (38) | 67 | (34) | 154 | (36) | ||
| Mild | 96 | (42) | 94 | (48) | 190 | (44) | ||
| Moderate/severe | 48 | (21) | 36 | (18) | 84 | (20) | ||
MDS, myelodysplastic syndrome; RIC, reduced-intensity conditioning; MAC, myeloablative conditioning; K, thousands of US dollars annually.
⁎
Long-term partner included patients who reported being married or living with their partner. Patients who reported being single, separated, divorced, or widowed were classified as lacking a long-term partner.
†
cGVHD status was only asked of allogeneic HCT recipients. As such, this question was not answered by autologous HCT recipients (n = 628). Among allogeneic HCT recipients, 80 responses to this question were missing.